Analysis of Bcl-2 Protein Expression in Chronic Lymphocytic Leukemia
Open Access
- 1 February 2000
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 113 (2) , 219-229
- https://doi.org/10.1309/491w-l1tn-ufqx-t61b
Abstract
A number of studies revealed that high expression of the proto-oncogene bcl-2 correlated with poor prognosis or resistance to chemotherapy in some tuKeywords
This publication has 35 references indexed in Scilit:
- BCL-2 FAMILY: Regulators of Cell DeathAnnual Review of Immunology, 1998
- Elevated Bcl-2/Bax Are a Consistent Feature of Apoptosis Resistance in B-cell Chronic Lymphocytic Leukaemia and Are Correlated withIn VivoChemoresistanceLeukemia & Lymphoma, 1998
- Expression of Apo‐1/Fas (CD95), Bcl‐2, Bax and Bcl‐x in myeloma cell lines: relationship between responsiveness to anti‐Fas mab and p53 functional statusBritish Journal of Haematology, 1997
- Comparative quantitative expression of bcl‐2 by normal and leukaemic myeloid cellsBritish Journal of Haematology, 1995
- Apoptosis suppressing protein bcl‐2 is expressed in well‐differentiated breast carcinomas with favourable prognosisThe Journal of Pathology, 1995
- Heterogeneity in cell proliferation and expression of p53 and bcl‐2 during the indolent phase of germinal centre cell lymphoma: an explanation for clinical variabilityBritish Journal of Haematology, 1995
- Effect of anti-APO1 on Spontaneous Apotosis of B Cells in Chronic Lymphocytic Leukaemia: The Role of bel-2 and Interleukin 4Leukemia & Lymphoma, 1995
- bcl-2 Protein in Non-Small-Cell Lung CarcinomaNew England Journal of Medicine, 1993
- Quality control in immunocytochemistry: experiences with the oestrogen receptor assay.Journal of Clinical Pathology, 1992
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984